Skip to main content
. 2015 Sep 8;6(31):31378–31398. doi: 10.18632/oncotarget.5145

Figure 11. Activation of MET signaling blocks myogenic differentiation and promotes rhabdomyosarcoma development, angiogenesis and malignancy.

Figure 11

A. Mechanism of a development of malignant tumor by the constitutive activation of the MET receptor signaling in ERMS. B. Mechanism of the effect of the aberrant MET receptor activation leading to myogenic differentiation.